Indefinite Delivery Contract SPE2DR25D9161

The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) and DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $499,999,999 IDC, valid through November 2026, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. This includes branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications.

The IDC was awarded under the DLA Troop Support Medical Supply Chain's planned solicitation for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contracts, which aims to establish multiple regional prime vendor contracts to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency, U.S. Coast Guard, and U.S. Naval Fleet. The contracts will have a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. The solicitation is expected to be issued in March 2024 and remain open for 45 days, with a pre-proposal vendor conference scheduled prior to the closing date.